Skip to main content
$0.990 0.060 (6.45%)

High

$1.02

Low

$0.93

Trades

390

Turnover

$1,053,513

Volume

1,077,429
30 June 2023 at 4:10pm
If you were already registered, log in here.

[ARTICLE] Paradigm Biopharmaceuticals blues with Morgans

A news article has been posted about Paradigm Biopharmaceuticals on the AFR. The article was published around , on 13 March 2022 at 4:05pm.

Any Morgans clients who moved quickly on the retail broker’s advice to dump Paradigm Biopharmaceuticals must be ruing their timing.

Read Article

PAR was $1.20 at the close of trade on 11 March 2022

Recent Articles about ASX:PAR
1-Nov Appendix 3H - Notification of cessation of securities - AFR

company-announcements.afr.com

30-Oct September 2026 Quarterly Activities Report - AFR

company-announcements.afr.com

29-Oct Convening Period for Second Meeting of Creditors Extended to 27 ...

company-announcements.afr.com

24-Oct Further Obsidian Note Redemption - AFR

company-announcements.afr.com

23-Oct Application for extension of the convening period for second ... - AFR

company-announcements.afr.com

22-Oct 2026 Notice of Annual General Meeting - AFR

company-announcements.afr.com

21-Oct Expiry of PAROB Listed Options – Company in Voluntary ... - AFR

company-announcements.afr.com

21-Oct Further Obsidian Note Redemption and Phase 3 Data Review Update

company-announcements.afr.com

21-Oct Appendix 3H - Notification of cessation of securities - AFR

company-announcements.afr.com

21-Oct 30 September 2026 ASX ANNOUNCEMENT - AFR

company-announcements.afr.com

Tracked

Find all articles about Paradigm Biopharmaceuticals, including others on the AFR, on the media page.

If you were already registered, log in here.

If you were already registered, log in here.

If you were already registered, log in here.